Sutro Biopharma, Inc.
NASDAQ:STRO
0.8715 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 62.043 | 153.731 | 67.772 | 61.88 | 42.722 | 42.736 | 38.419 | 51.741 | 59.731 |
| Kosten van de omzet
| 7.218 | 6.816 | 8.288 | 9.773 | 76.961 | 65.612 | 54.262 | 51.897 | 43.55 |
| Brutowinst
| 54.825 | 146.915 | 59.484 | 52.107 | -34.239 | -22.876 | -15.843 | -0.156 | 16.181 |
| Brutowinstmarge
| 0.884 | 0.956 | 0.878 | 0.842 | -0.801 | -0.535 | -0.412 | -0.003 | 0.271 |
| Onderzoek- en ontwikkelingskosten
| 252.043 | 180.425 | 137.171 | 104.4 | 76.961 | 65.612 | 54.262 | 54.639 | 43.55 |
| Algemene en administratieve kosten
| 48.453 | 62.584 | 59.544 | 56.004 | 36.818 | 32.592 | 21.38 | 16.374 | 14.817 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 48.453 | 62.584 | 59.544 | 56.004 | 36.818 | 32.592 | 21.38 | 16.374 | 14.817 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0 | -4.35 | 1.913 | -0.077 | 0.087 |
| Bedrijfskosten
| 300.496 | 243.009 | 196.715 | 160.404 | 113.779 | 98.204 | 75.642 | 71.013 | 58.367 |
| Bedrijfsresultaat
| -238.453 | -89.278 | -128.943 | -98.524 | -71.057 | -55.468 | -37.223 | -19.272 | 1.364 |
| Bedrijfsresultaat ratio
| -3.843 | -0.581 | -1.903 | -1.592 | -1.663 | -1.298 | -0.969 | -0.372 | 0.023 |
| Totaal overige inkomsten en kosten netto
| 13.355 | 0.677 | 12.239 | -7.014 | 38.929 | -0.276 | 1.906 | -0.416 | 0.338 |
| Inkomen voor belasting
| -225.098 | -88.601 | -116.704 | -105.538 | -32.128 | -55.744 | -35.317 | -19.688 | 1.702 |
| Inkomen voor belasting ratio
| -3.628 | -0.576 | -1.722 | -1.706 | -0.752 | -1.304 | -0.919 | -0.381 | 0.028 |
| Belastingkosten
| 2.363 | 18.192 | 2.5 | 3.137 | 4.077 | 8.679 | 3.529 | 0.535 | 0.087 |
| Nettowinst
| -227.461 | -106.793 | -119.204 | -108.675 | -36.205 | -55.744 | -35.317 | -19.688 | 1.702 |
| Nettowinstmarge
| -3.666 | -0.695 | -1.759 | -1.756 | -0.847 | -1.304 | -0.919 | -0.381 | 0.028 |
| WPA (Winst Per Aandeel)
| -2.96 | -1.78 | -2.35 | -2.36 | -1.11 | -2.43 | -6.13 | -2.81 | 0.24 |
| Verwaterde WPA
| -2.96 | -1.78 | -2.35 | -2.36 | -1.11 | -2.43 | -6.13 | -2.81 | 0.24 |
| EBITDA
| -180.453 | -67.915 | -105.07 | -98.524 | -23.754 | -46.617 | -32.817 | -14.086 | 7.364 |
| EBITDA ratio
| -2.909 | -0.442 | -1.55 | -1.592 | -0.556 | -1.091 | -0.854 | -0.272 | 0.123 |